Association  	Association  	 NNP	O
of  	of  	 IN	O
serum  	serum  	 JJ	B-NP
folic  	folic  	 JJ	I-NP
acid  	acid  	 NN	I-NP
and  	and  	 CC	O
homocysteine  	homocysteine  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
and  	and  	 CC	O
5 	5 	 CD	O
,  	,  	 ,	O
10-methylenetetrahydrofolate  	10-methylenetetrahydrofolate  	 CD	O
reductase  	reductase  	 JJ	B-NP
gene  	gene  	 NN	I-NP
polymorphism  	polymorphism  	 NN	I-NP
with  	with  	 IN	O
schizophrenia  	schizophrenia  	 NN	O
To  	To  	 TO	O
explore  	explore  	 VB	O
the  	the  	 DT	O
association  	association  	 NN	O
between  	between  	 IN	O
serum  	serum  	 JJ	B-NP
concentrations  	concentrations  	 NNS	I-NP
of  	of  	 IN	I-NP
folic  	folic  	 JJ	I-NP
acid  	acid  	 NN	I-NP
and  	and  	 CC	O
homocysteine  	homocysteine  	 NNS	B-NP
( 	( 	 -LRB-	O
HCY 	HCY 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
5 	5 	 CD	O
,  	,  	 ,	O
10-methylenetetrahydrofolate  	10-methylenetetrahydrofolate  	 CD	O
reductase  	reductase  	 NNS	O
( 	( 	 -LRB-	O
MTHFR 	MTHFR 	 NNP	B-NP
)  	)  	 -RRB-	O
C667T  	C667T  	 CD	O
polymorphism  	polymorphism  	 NNS	O
and  	and  	 CC	O
schizophrenia 	schizophrenia 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
130  	130  	 CD	O
schizophrenics  	schizophrenics  	 NNS	O
( 	( 	 -LRB-	O
schizophrenia  	schizophrenia  	 JJ	B-NP
group 	group 	 NN	I-NP
)  	)  	 -RRB-	O
from  	from  	 IN	O
our  	our  	 PRP$	O
hospital  	hospital  	 NN	O
and  	and  	 CC	O
80  	80  	 CD	O
healthy  	healthy  	 JJ	O
individuals  	individuals  	 NNS	O
( 	( 	 -LRB-	O
control  	control  	 NN	B-NP
group 	group 	 NN	I-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
enrolled 	enrolled 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
serum  	serum  	 JJ	B-NP
concentration  	concentration  	 NN	I-NP
of  	of  	 IN	I-NP
homocysteine  	homocysteine  	 NN	I-NP
was  	was  	 VBD	O
measured  	measured  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
electrochemical  	electrochemical  	 JJ	B-NP
luminescence  	luminescence  	 JJ	I-NP
method 	method 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
concentration  	concentration  	 NN	B-NP
of  	of  	 IN	I-NP
serum  	serum  	 JJ	I-NP
folic  	folic  	 JJ	I-NP
acid  	acid  	 NN	I-NP
by  	by  	 IN	O
enzymatic  	enzymatic  	 JJ	B-NP
cycling  	cycling  	 NN	I-NP
assay  	assay  	 NNS	I-NP
and  	and  	 CC	O
MTHFR  	MTHFR  	 NNP	O
C667T  	C667T  	 NNP	O
genotype  	genotype  	 NN	O
by  	by  	 IN	O
PCR-DNA  	PCR-DNA  	 JJ	B-NP
microarray 	microarray 	 NN	I-NP
.  	.  	 .	O
And  	And  	 CC	O
positive  	positive  	 JJ	B-NP
and  	and  	 CC	I-NP
negative  	negative  	 JJ	I-NP
syndrome  	syndrome  	 NN	I-NP
scale  	scale  	 NN	I-NP
( 	( 	 -LRB-	O
PANSS 	PANSS 	 NNP	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
mental  	mental  	 JJ	B-NP
symptoms.  	symptoms.  	 NNP	I-NP
( 	( 	 -LRB-	O
1 	1 	 LS	O
)  	)  	 -RRB-	O
Serum  	Serum  	 NNP	B-NP
HCY  	HCY  	 NNP	I-NP
level  	level  	 NN	I-NP
in  	in  	 IN	O
schizophrenia  	schizophrenia  	 JJ	B-NP
group  	group  	 NN	I-NP
was  	was  	 VBD	O
higher  	higher  	 JJR	O
than  	than  	 IN	O
that  	that  	 DT	O
in  	in  	 IN	O
control  	control  	 NN	B-NP
group  	group  	 NN	I-NP
[ 	[ 	 -LRB-	O
( 	( 	 -LRB-	O
20  	20  	 CD	O
±  	±  	 CD	O
10 	10 	 CD	O
)  	)  	 -RRB-	O
vs  	vs  	 NNS	O
( 	( 	 -LRB-	O
11  	11  	 CD	O
±  	±  	 CD	O
3 	3 	 CD	O
)  	)  	 -RRB-	O
µmol 	µmol 	 FW	B-NP
/ 	/ 	 FW	I-NP
L 	L 	 NNP	I-NP
;  	;  	 :	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.001 	0.001 	 NNP	O
]  	]  	 -RRB-	O
while  	while  	 IN	O
serum  	serum  	 JJ	B-NP
folate  	folate  	 JJ	I-NP
level  	level  	 NN	I-NP
in  	in  	 IN	O
schizophrenia  	schizophrenia  	 JJ	B-NP
group  	group  	 NN	I-NP
was  	was  	 VBD	O
lower  	lower  	 JJR	O
than  	than  	 IN	O
that  	that  	 DT	O
in  	in  	 IN	O
control  	control  	 NN	B-NP
group  	group  	 NN	I-NP
[ 	[ 	 -LRB-	O
( 	( 	 -LRB-	O
6  	6  	 CD	O
±  	±  	 CD	O
4 	4 	 CD	O
)  	)  	 -RRB-	O
vs  	vs  	 NNS	O
( 	( 	 -LRB-	O
9  	9  	 CD	O
±  	±  	 CD	O
3 	3 	 CD	O
)  	)  	 -RRB-	O
ng 	ng 	 FW	B-NP
/ 	/ 	 FW	I-NP
ml 	ml 	 FW	I-NP
;  	;  	 :	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.001 	0.001 	 NNP	O
] 	] 	 -RRB-	O
;  	;  	 :	O
( 	( 	 -LRB-	O
2 	2 	 LS	O
)  	)  	 -RRB-	O
the  	the  	 DT	O
frequencies  	frequencies  	 NN	O
of  	of  	 IN	O
CC 	CC 	 NNP	O
,  	,  	 ,	O
CT  	CT  	 NNP	B-NP
and  	and  	 CC	O
TT  	TT  	 NNP	B-NP
in  	in  	 IN	O
MTHFR  	MTHFR  	 NNP	O
C677T  	C677T  	 NNP	O
alleles  	alleles  	 NN	O
were  	were  	 VBD	O
13.1 	13.1 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
50.0 	50.0 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
36.9 	36.9 	 CD	O
%  	%  	 NN	O
in  	in  	 IN	O
schizophrenia  	schizophrenia  	 JJ	B-NP
group  	group  	 NN	I-NP
versus  	versus  	 IN	O
30.0 	30.0 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
47.5 	47.5 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
22.5 	22.5 	 CD	O
%  	%  	 NN	O
in  	in  	 IN	O
control  	control  	 NN	B-NP
group  	group  	 NN	I-NP
respectively 	respectively 	 RB	O
.  	.  	 .	O
Statistical  	Statistical  	 JJ	B-NP
significant  	significant  	 JJ	I-NP
inter-group  	inter-group  	 JJ	I-NP
difference  	difference  	 NN	I-NP
existed  	existed  	 VBD	O
in  	in  	 IN	O
the  	the  	 DT	O
frequencies  	frequencies  	 NN	O
of  	of  	 IN	O
genotypes  	genotypes  	 NNS	B-NP
( 	( 	 -LRB-	O
χ²  	χ²  	 CD	O
=  	=  	 SYM	O
36.806 	36.806 	 CD	O
,  	,  	 ,	O
P  	P  	 NN	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
frequencies  	frequencies  	 NN	O
of  	of  	 IN	O
T  	T  	 NN	O
and  	and  	 CC	O
C  	C  	 NNP	O
alleles  	alleles  	 NN	B-NP
were  	were  	 VBD	O
61.9 	61.9 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
38.1 	38.1 	 CD	O
%  	%  	 NN	O
in  	in  	 IN	O
schizophrenia  	schizophrenia  	 JJ	B-NP
group  	group  	 NN	I-NP
versus  	versus  	 IN	O
46.25 	46.25 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
53.75 	53.75 	 CD	O
%  	%  	 NN	O
in  	in  	 IN	O
control  	control  	 NN	B-NP
group  	group  	 NN	I-NP
respectively 	respectively 	 RB	O
.  	.  	 .	O
Statistical  	Statistical  	 JJ	B-NP
significant  	significant  	 JJ	I-NP
inter-group  	inter-group  	 JJ	I-NP
difference  	difference  	 NN	I-NP
existed  	existed  	 VBD	O
in  	in  	 IN	O
the  	the  	 DT	O
frequency  	frequency  	 NN	O
of  	of  	 IN	O
T  	T  	 NN	B-NP
allele  	allele  	 NNS	I-NP
( 	( 	 -LRB-	O
χ²  	χ²  	 CD	O
=  	=  	 SYM	O
9.872 	9.872 	 CD	O
,  	,  	 ,	O
P  	P  	 NN	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
frequency  	frequency  	 NN	O
of  	of  	 IN	O
TT  	TT  	 NNP	B-NP
genotype  	genotype  	 NN	I-NP
in  	in  	 IN	O
schizophrenia  	schizophrenia  	 JJ	B-NP
group  	group  	 NN	I-NP
was  	was  	 VBD	O
61.9 	61.9 	 CD	O
%  	%  	 NN	O
versus  	versus  	 IN	O
22.5 	22.5 	 CD	O
%  	%  	 NN	O
in  	in  	 IN	O
control  	control  	 NN	B-NP
group 	group 	 NN	I-NP
.  	.  	 .	O
Statistically  	Statistically  	 RB	O
significant  	significant  	 JJ	O
inter-group  	inter-group  	 JJ	B-NP
difference  	difference  	 NN	I-NP
existed  	existed  	 VBD	O
in  	in  	 IN	O
the  	the  	 DT	O
frequency  	frequency  	 NN	O
of  	of  	 IN	O
TT  	TT  	 NNP	B-NP
homozygous  	homozygous  	 FW	I-NP
mutation  	mutation  	 FW	I-NP
( 	( 	 -LRB-	O
χ²  	χ²  	 CD	O
=  	=  	 SYM	O
4.780 	4.780 	 CD	O
,  	,  	 ,	O
P  	P  	 NN	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
;  	;  	 :	O
( 	( 	 -LRB-	O
3 	3 	 LS	O
)  	)  	 -RRB-	O
correlation  	correlation  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
showed  	showed  	 VBD	O
that  	that  	 DT	O
serum  	serum  	 JJ	B-NP
folate  	folate  	 JJ	I-NP
level  	level  	 NN	I-NP
in  	in  	 IN	O
schizophrenia  	schizophrenia  	 JJ	B-NP
group  	group  	 NN	I-NP
had  	had  	 VBD	O
a  	a  	 DT	O
negative  	negative  	 JJ	B-NP
correlation  	correlation  	 NN	I-NP
with  	with  	 IN	O
HCY  	HCY  	 NNP	B-NP
level  	level  	 NN	I-NP
( 	( 	 -LRB-	O
r  	r  	 LS	O
=  	=  	 SYM	O
-0.418 	-0.418 	 CD	O
,  	,  	 ,	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.001 	0.001 	 NNP	O
)  	)  	 -RRB-	O
.  	.  	 .	O
Serum  	Serum  	 NNP	B-NP
HCY  	HCY  	 NNP	I-NP
level  	level  	 NN	I-NP
had  	had  	 VBD	O
a  	a  	 DT	O
positive  	positive  	 JJ	B-NP
correlation  	correlation  	 NN	I-NP
with  	with  	 IN	O
negative  	negative  	 JJ	B-NP
symptoms  	symptoms  	 NNS	I-NP
scores  	scores  	 NNS	I-NP
( 	( 	 -LRB-	O
r  	r  	 LS	O
=  	=  	 SYM	O
0.345 	0.345 	 CD	O
,  	,  	 ,	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.001 	0.001 	 NNP	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
serum  	serum  	 JJ	B-NP
folate  	folate  	 JJ	I-NP
level  	level  	 NN	I-NP
was  	was  	 VBD	O
negatively  	negatively  	 RB	O
correlated  	correlated  	 VBN	O
with  	with  	 IN	O
negative  	negative  	 JJ	B-NP
symptoms  	symptoms  	 NNS	I-NP
scores  	scores  	 NNS	I-NP
( 	( 	 -LRB-	O
r  	r  	 LS	O
=  	=  	 SYM	O
-0.386 	-0.386 	 CD	O
,  	,  	 ,	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.001 	0.001 	 NNP	O
) 	) 	 -RRB-	O
;  	;  	 :	O
( 	( 	 -LRB-	O
4 	4 	 LS	O
)  	)  	 -RRB-	O
the  	the  	 DT	O
serum  	serum  	 JJ	B-NP
HCY  	HCY  	 NNP	I-NP
level  	level  	 NN	I-NP
in  	in  	 IN	O
schizophrenia  	schizophrenia  	 JJ	B-NP
group  	group  	 NN	I-NP
with  	with  	 IN	O
TT  	TT  	 NNP	B-NP
genotype  	genotype  	 NN	I-NP
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
than  	than  	 IN	O
those  	those  	 DT	O
with  	with  	 IN	O
CC  	CC  	 NNP	O
and  	and  	 CC	O
CT  	CT  	 NNP	B-NP
genotypes  	genotypes  	 NNS	I-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
There  	There  	 EX	O
is  	is  	 VBZ	O
a  	a  	 DT	O
certain  	certain  	 JJ	O
correlation  	correlation  	 NN	O
between  	between  	 IN	O
the  	the  	 DT	O
serum  	serum  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
folate  	folate  	 NN	I-NP
and  	and  	 CC	O
HCY  	HCY  	 NNP	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
symptoms  	symptoms  	 NNS	B-NP
of  	of  	 IN	O
schizophrenia 	schizophrenia 	 NN	O
.  	.  	 .	O
And  	And  	 CC	O
MTHFR  	MTHFR  	 NNP	O
C677T  	C677T  	 NNP	O
polymorphism  	polymorphism  	 NN	O
is  	is  	 VBZ	O
a  	a  	 DT	O
possible  	possible  	 JJ	O
risk  	risk  	 NN	B-NP
factor  	factor  	 NN	I-NP
for  	for  	 IN	O
schizophrenia 	schizophrenia 	 NN	O
.  	.  	 .	O
